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It  has been  well  documented  that  human  T  cells  that  have been  stimulated  in 
unidirectional  allogeneic mixed leukocyte cultures  (MLC)  may express surface anti- 
gens that are not detectable in resting T  cells (1,  2).  For example, HLA-DR (or Ia) 
antigens  have been demonstrated on the surface of >60% of MLC T  cells, whereas 
<6%  of normal  T  cells  have  been  found  to  be  positive  for  these  markers  (3-5). 
Similarly, 4F2 antigen, a  120,000-mol wt protein normally found in peripheral blood 
monocytes (6), is not detectable in resting T  cells, but is expressed in MLC stimulated 
T  cells (7, 8). 
Unlike resting T  cells (9,  10),  MLC-stimulated T  cells can be propagated in vitro 
in the presence of interleukin 2 (IL-2) (11).  In addition, IL-2 has been used to derive 
functional T  cell clones (12-14). These clones express relatively large amounts of both 
Ia and 4F2 antigens irrespective of their functional activity (15). 
In this study, we analyzed whether Ia and/or 4F2 antigens were involved in IL-2- 
dependent T  cell proliferation. It will be shown that addition of D1/12 monoclonal 
antibody (Mab)  directed against nonpolymorphic Ia determinants  (16,  17)  strongly 
inhibited  IL-2 dependent  proliferation of human MLC T  cells and a  cloned T  cell 
line. In contrast, addition of anti-4F2 Mab had no effect on the proliferative response 
of human  MLC  or  cloned  T  cells  to  IL-2.  Moreover,  addition  of D1/12  Mab  to 
murine MLC T  cells, which do not express the determinants defined by D1/12 Mab, 
caused  no  inhibition  of their  proliferation  induced  by  the  same  source  of human 
IL-2. 
Materials and Methods 
Monodonal Antibodies.  Derivation of the two hybridoma antibodies (Mab) used in the present 
study has been described previously (16, 17). The anti-Ia DI/12 Mab is an IgG2 antibody 
directed to nonpolymorphic determinants of human Ia molecules; 4F2 Mab is an IgG2 antibody 
reacting against a 120,000-mol wt cell surface antigen expressed on peripheral blood monocytes 
and on activated T cells (7, 8). The two monoclonals were used under the form of purified IgG 
at a dose of 10 #g/well unless otherwise specified. 
Indicator Cell System.  Human MLC T  cells were obtained from unidirectional  7-d  MLC 
containing  106  responding  peripheral  blood  lymphocytes and  106  irradiated  (5,000  rad) 
allogeneic cells as described previously (18). T cells were purified according to their capacity to 
form spontaneous rosettes  with sheep erythrocytes and stored frozen  in liquid nitrogen until 
used.  Clone  16  is  a  human  T  cell  clone obtained  from MLC  T  cells by limiting dilution 
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techniques. The  growth of clone  16 cells is dependent  upon the presence of exogenous IL-2 in 
the  culture  medium.  The  cells  grow  without  the  presence  of feeder  cells,  do  not  express Fc 
receptors for IgG, but express both Ia and 4F2 antigens. The functional properties as well as the 
surface phenotype  of clone  16 cells have been described  in a  previous report  (15).  Long-term 
MLC  murine  cells  were  obtained  as  described  elsewhere  (19)  from  14-d  MLC  cultures 
containing C57BL/6  responding spleen cells and irradiated  DBA/2  stimulating spleen cells. 
Source of IL-2.  Supernatants  containing IL-2 activity were obtained from cultures of human 
spleen  cells  stimulated  with  phytohemagglutin  (PHA)  as  described  in  detail  elsewhere  (20). 
Supernatants  were  depleted  of PHA  by  two-step  sequential  precipitation  with  40  and  80%- 
saturated ammonium  sulphate (SAS)  as previously described  (21).  The 80%  SAS-precipitated 
material was dialyzed and  resuspended in a  volume of RPMI  1640 medium  corresponding to 
one half of the original culture volume. 
Assay for IL-2 Activity.  104  indicator cells  (human  or mouse MLC  cells and  clone  16 cells) 
were cultured for 72 h  in RPMI  1640 medium  (Gibco Bio-Ag, Basel Switzerland) supplemented 
with  10%  fetal  calf serum  FCS  (Gibco  Bio-Ag)  in  round-bottomed  microtiter  trays  (Greiner 
Labor Teeknik,  Nurtingen, Germany).  IL-2-containing medium  was added  at a  final dilution 
of 1:2 (total volume 200 #1). [3H]thymidine (TdR) was added  (0.1/.tCi/well,  sp act 9 mCi/mM) 
6  h  before harvesting the cultures. The uptake was determined according to Greaves et al. (22). 
The counts per minute reported  represent the mean  value of triplicate cultures. 
Results  and Discussions 
In a  first series of experiments,  104 human MLC  T  cells were cultured with IL-2- 
containing medium  in  the presence or absence of D1/12  or 4F2  hybridoma culture 
supernatant  (final dilution,  1:20). Table I displays the results of three representative 
experiments. In the presence of D 1/12 Mab, IL-2-induced proliferation was markedly 
inhibited.  Dose-response analysis showed that  >90%  inhibition of proliferation  was 
observed  in  cultures containing  D1/12  hybridoma supernatant  diluted  up  to  1:160 
(corresponding  to  ~1.25  #g  antibody  IgG)  (Fig.  1).  In  contrast,  no  inhibition  of 
proliferation was found in the presence of a  1:20 dilution of either 4F2 hybridoma or 
TABL~  I 
Effect  of D1~12 Mab on the Proliferative Capacity of MLC T Cells in 
Response to IL-2 
Experiment  IL-2* added  Mab added$  [aH]TdR uptake§ 
cpm 
-  None  1626 ± 304 
+  None  28342 ±  789 
+  DI/12  4828 ± 377 
+  4F2  26431 ±  I722 
+  PX63  29004 ±  2421 
-  None  984 ± 92 
+  None  35155 ± 2644 
+  D1/12  3831 ±  182 
+  4F2  32480 ±  1922 
+  PX63  33631 ± 2862 
-  None  633 + 46 
+  None  21902 ±  1561 
+  D1/I2  2346 ± 255 
+  4F2  20686 ±  1044 
+  PX63  19799 ± 2643 
* 100/xl of IL-2-containing  medium (see Materials and Methods) was added to  100/~1 of 
culture medium containing 104 indicator cells. 
:l: 10 ~g of purified  IgG of the different Mab listed were added at the onset of the culture. 
§ After 3 d of culture, cells were pulsed with [SH]TdR for 4 h. Values are expressed as 
mean counts per minute ± standard deviation of triplicate cultures. MORETTA  ET AL.  BRIEF DEFINITIVE REPORT  601 
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FI~.  1.  Effect  of addition of different amounts of D1/12 or 4F2 Mab on the proliferative capacity 
of human MLC-T cells in response to human IL-2. Triplicate microwell cultures of 1 ×  104 primary 
MLC T cells were set up in RPMI medium with 10% FCS, 50% vol/vol of IL-2-containing medium 
and the amount of specific Mab listed in the abscissa (total culture volume: 200 FI). After 3 d of 
culture, cell proliferation was evaluated by adding 0.1/~Ci/well of [aH]TdR as described in Materials 
and Methods. O, D 1  / 12; A, 4F2. Abscissa, amount of Mab added in p,g of purified IgG; ordinate, 
percent inhibition of [3H]TdR uptake as compared to control cultures in which the addition of Mab 
was omitted. 
parent  myeloma PX63  culture supernatant  (Table I). Similar results were obtained 
in  nine  additional experiments involving different responder-stimulator cell combi- 
nations. 
Given  (a)  the ability of MLC  T  cell populations to mediate antibody-dependent 
lysis (23, 24), and  (b) the large proportion of MLC T  ceils bearing Ia antigens, these 
results could have been explained by the killing of D 1/12 Mab-coated cells by effector 
cells present in the MLC populations. To rule out this possibility, we tested the effect 
of  D1/12  Mab  on  II-2-induced  proliferation  of  a  cloned  T  cell  line.  As  shown 
previously (15), clone  16 cells do not bear Fc receptors for IgG, nor do they mediate 
antibody-dependent lysis. As assessed by flow cytofluorometry, Ia and 4F2 antigens 
are expressed in similar amounts on the surface of clone 16 cells (data not shown). As 
shown  in  Table  II,  the  proliferation of clone  16  cells in  the  presence  of IL-2  was 
markedly inhibited in cultures containing D 1/12 Mab, but was unaffected in cultures 
containing 4F2 Mab or PX63 culture supernatant. 
Because these results indicated that inhibition of proliferation by D1/12 Mab was 
not caused by antibody-dependent cell-mediated lysis of Ia  + T  cells, we then consid- 
ered  the possibility that  D1/12  Mab  could  functionally inactivate the human  IL-2 
preparation  used  in  this  study.  If this was  the case,  the  inhibitory effect  of D1/12 
Mab  on  IL-2-induced proliferation would be exerted independently of the presence 
of Ia antigens on IL-2-responding T  cell populations. 
Because human  IL-2 has been shown to be active on murine T  cells (25), we used 
long-term  C57BL/6  anti-DBA/2  MLC  cells  (19)  as a  source of IL-2-responding T 
cells. These cells, after 3 d  of culture in the presence of human  IL-2, exhibit a  strong 
proliferative response upon reexposure to human  IL-2 (Table III). However, they do 602  MORETTA  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Effect of D l /12 Mab on the Proliferative  Capacity of Clone 16 Cells in 
Response to IL-2 
Experiment  IL-2* added  Mab added$  aHTdR uptake§ 
COm 
1  -  None  564 ±  188 
+  None  61204 ±  7382 
+  DI/12  7342 ±  1077 
+  4F2  64826 :t: 9881 
+  PX63  60300 ±  4223 
2  -  None  301  ±  82 
+  None  42877  ±  3566 
+  DI/12  3919 ±  655 
+  4F2  40872 ±  2993 
+  PX63  41624 ±  2773 
3  -  None  634 ±  128 
+  None  33622 ±  926 
+  D1/12  2977 ±  645 
+  4F2  30428 ±  1076 
+  PX63  31977 ±  2322 
* As in Table I. 
$ As in Table I. 
§ As in Table I. 
TABLE  III 
Addition  of D l /12 Mab Does Not Inhibit the Proliferation Response of 
Murine MLC Cells to Human IL-2 
Experiment  IL-2* added  Mah added$  [3H]TdR uptake§ 
cOrn 
-  None  328 ±  73 
+  None  18831  ±  344 
+  D1/12  17446 ±  478 
+  4F2  17881  ±  422 
-  None  252 ±  61 
+  None  23287  ±  1941 
+  DI/12  21844 ±  2001 
+  4F2  23064±  3614 
--  None  227 ±  40 
+  None  16871  ±  918 
+  D1/12  15990 ±  333 
+  4F2  15443 ±  722 
*  100  /xl  of human  IL-2-containing  medium  was  added  to  100  /xl  of culture  medium 
containing  104 murine MLC cells derived from C57BL/6 anti-DBA/2  long-term MLC 
as described previously (19). 
$ As in Table I. 
§ As in Table 1. 
not  react  with  D1/12  Mab  as  assessed  by  quantitative  immunofluorescence  and 
complement-dependent  lysis  (data  not  shown).  Table  III shows  that  addition  of 
D1/12  Mab to cultures of murine MLC cells had no effect on human IL-2-indueed 
proliferation. 
Further evidence that D1/12 Mab did not react with human IL-2 was provided by 
the  demonstration  that  IL-2-containing  supernatants  that  had  been  twice  passed 
through  an  immunoadsorbent  column  of  D1/12  Mab  coupled-Sepharose  beads 
showed no decrease in IL-2 activity (data not shown). MORETTA ET AL.  BRIEF  DEFINITIVE REPORT  603 
These experiments clearly indicate that the inhibition of IL-2-induced proliferation 
of human MLC-T cells  is a  consequence of a  direct interaction of D1/12 Mab with 
surface Ia molecules. The precise mechanism(s) by which anti-Ia Mab inhibits T  cell 
proliferation  has still  to  be  determined.  Several  possibilities  can  be envisaged:  (a) 
Anti-Ia Mab may inhibit the binding of IL-2 to the corresponding surface receptors 
by steric  hindrance.  Previous  studies  have  shown  that  D1/12  Mab  reacts  with  a 
specific subset of human Ia antigens accounting for only a  portion of the human Ia 
molecular pool (16,  17). Therefore, if the above mentioned mechanism is correct, one 
should  envisage  a  topographic  close  association  between  IL-2  receptors  and  this 
limited portion ofla molecules. (b) Ia molecules may participate in the cellular events 
required  for  the  transmission  of the  signal(s)  given  by  IL-2 and  resulting  in  cell 
proliferation. Studies are in progress in our laboratory to discriminate between these 
or other possibilities. 
Summary 
We  have  studied  the  effect  on  the  interleukin  (IL-)  2-dependent  human  T  cell 
growth of two distinct monoclonal antibodies (Mab), D1-12 and 4F2, with specificity 
for common determinant  of human  Ia antigens  and  for  a  differentiation  antigen 
expressed on all activated T  cells,  respectively. Strong inhibition of cell growth was 
found  in  cultures  supplemented  with  the  anti-Ia  Dl-12  Mab  but  not  in  cultures 
supplemented with 4F2 Mab.  These results were obtained when either total mixed 
leukocyte  culture  (MLC)  T  cells  or  an  MLC-derived  T  cell  clone  were  used  as 
indicator cell systems for IL-2 activity. 
The inhibition of cell growth appears to be mediated by a direct interaction of D 1- 
12  Mab  with  the  cells  and  not  by a  direct  inactivation  of the  growth  factor,  as 
addition of the antibody to murine MLC T cells, which do not express the determinant 
defined by D1-12 Mab, resulted in no inhibition of their proliferation induced by the 
same source of human IL-2. 
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